The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
Open accessAbstract
miR-122 is a liver-specific microRNA that positively regulates hepatitis C virus (HCV) RNA abundance and is essential for production of infectious HCV. Using a genetic approach, we show that its ability to enhance yields of infectious virus is dependent upon two miR-122-binding sites near the 5′ end of the HCV genome, S1 and S2. Viral RNA with base substitutions in both S1 and S2 failed to produce infectious virus in transfected cells, while virus production was rescued to near-wild-type levels in cells supplemented with a complementary miR-122 mutant. A comparison of mutants with substitutions in only one site revealed S1 to be dominant, as an S2 but not S1 mutant produced high virus yields in cells supplemented with wild-type miR-122. Translation of HCV RNA was reduced over 50% by mutations in either S1 or S2 and was partially rescued by transfection of the complementary miR-122 mutant. Unlike the case for virus replication, however, both sites function equally in regulating translation. We conclude that miR-122 promotes replication by binding directly to both sites in the genomic RNA and, at least in part, by stimulating internal ribosome entry site (IRES)-mediated translation. However, a comparison of the replication capacities of the double-binding-site mutant and an IRES mutant with a quantitatively equivalent defect in translation suggests that the decrement in translation associated with loss of miR-122 binding is insufficient to explain the profound defect in virus production by the double mutant. miR-122 is thus likely to act at an additional step in the virus life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“It is a key regulator of lipid and cholesterol biosynthesis in the liver (4, 5, 20).”
BackgroundSwitching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,521
Self-citationmiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 2×
“It is a key regulator of lipid and cholesterol biosynthesis in the liver (4, 5, 20).”
BackgroundTherapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR
Lytle, J. R., Yario, T. A., & Steitz, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703820104 · Cited by 1,196
Getting to the Root of miRNA-Mediated Gene Silencing
Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008) · Cell · doi:10.1016/j.cell.2007.12.024 · Cited by 1,079
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T., Bort, R., et al. (2004) · RNA Biology · doi:10.4161/rna.1.2.1066 · Cited by 811
Pestova, T. V., Shatsky, I. N., Fletcher, S. P., Jackson, R. J., & Hellen, C. U. T. (1998) · Genes & Development · doi:10.1101/gad.12.1.67 · Cited by 729
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
microRNA-122 stimulates translation of hepatitis C virus RNA
Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schüttler, C. G., Fehr, C., Jünemann, C., & Niepmann, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.244 · Cited by 679
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2
Vasudevan, S., & Steitz, J. A. (2007) · Cell · doi:10.1016/j.cell.2007.01.038 · Cited by 656 · cited 1×
“For example, miR-369-3p recruits Ago2 and fragile X mental retardation-related protein 1 (FXR1) to the AU-rich element (ARE) of tumor necrosis factor alpha (TNF- ) mRNA and activates TNF- translation in serum-starved cells (34, 35).”
BackgroundCellular cofactors affecting hepatitis C virus infection and replication
Randall, G., Panis, M., Cooper, J. D., Tellinghuisen, T. L., Sukhodolets, K. E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704894104 · Cited by 526
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
Gastaminza, P., Cheng, G., Wieland, S., Zhong, J., Liao, W., & Chisari, F. V. (2008) · Journal of Virology · doi:10.1128/jvi.02053-07 · Cited by 463
Jopling, C. L., Schütz, S., & Sarnow, P. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.013 · Cited by 427
Mechanism of ribosome recruitment by hepatitis C IRES RNA
KIEFT, J. S., ZHOU, K., JUBIN, R., & DOUDNA, J. A. (2001) · RNA · doi:10.1017/s1355838201001790 · Cited by 369
Ye, J., Wang, C., Sumpter, R., Brown, M. S., Goldstein, J. L., & Gale, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237238100 · Cited by 366
Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T., & Lemon, S. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510727103 · Cited by 357
Self-citationNielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2418-2428.2006 · Cited by 347
Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299
Kapadia, S. B., Barth, H., Baumert, T., McKeating, J. A., & Chisari, F. V. (2007) · Journal of Virology · doi:10.1128/jvi.01134-06 · Cited by 271
The Hepatitis C Virus Internal Ribosome Entry Site Adopts an Ion-dependent Tertiary Fold
Kieft, J. S., Zhou, K., Jubin, R., Murray, M. G., Lau, J. Y. N., & Doudna, J. A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3095 · Cited by 220
NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly
Ma, Y., Yates, J., Liang, Y., Lemon, S. M., & Yi, M. (2008) · Journal of Virology · doi:10.1128/jvi.00724-08 · Cited by 204
Self-citationStructure and function of HCV IRES domains
Lukavsky, P. J. (2009) · Virus Research · doi:10.1016/j.virusres.2008.06.004 · Cited by 201
Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus
Ye, J. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030108 · Cited by 155
Structure and Function of Skin
Monteiro-Riviere, N. A. (2010) · CRC Press eBooks · doi:10.3109/9781420079180-3 · Cited by 139
Scheller, N., Mina, L. B., Galão, R. P., Chari, A., Giménez‐Barcons, M., Noueiry, A. O., Fischer, U., Meyerhans, A., & Díez, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906413106 · Cited by 138
Jubin, R., Vantuno, N. E., Kieft, J. S., Murray, M. G., Doudna, J. A., Lau, J. Y. N., & Baroudy, B. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10430-10437.2000 · Cited by 111
Jangra, R. K., Yi, M., & Lemon, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.00397-10 · Cited by 109
Self-citationNorman, K., & Sarnow, P. (2009) · Journal of Virology · doi:10.1128/jvi.01156-09 · Cited by 103
Shimakami, T., Lanford, R. E., & Lemon, S. M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.008 · Cited by 47
Self-citation
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
miR-122 – A key factor and therapeutic target in liver disease
Bandiera, S., Pfeffer, S., Baumert, T. F., & Zeisel, M. B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.004 · Cited by 629
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N., & Beretta, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023937 · Cited by 564
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Metadata
- Authors
- Jangra, R. K., Yi, M., & Lemon, S. M.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-07
- Volume
- 84
- Issue
- 13
- Pages
- 6615-6625
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2114658861
- Cited by
- 306
- References
- 34
- FWCI
- 23.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.